Evidence map›Paper›PMID 35542907›Full record

ReviewRSC advances2018

Chitosan composite scaffolds for articular cartilage defect repair: a review.

Huijun Li, Cheng Hu, Huijun Yu, Chuanzhong Chen

Abstract readReview
In one paragraph

Review in RSC advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Huijun LiShenzhen Research Institute of Shandong University Shenzhen 518057 Guangdong P. R. China yhj2001@sdu.edu.cn czchen@sdu.edu.cn +86 531 88395991 +86 531 88395991.ORCID https://orcid.org/0000-0003-2614-8110
Cheng HuShenzhen Research Institute of Shandong University Shenzhen 518057 Guangdong P. R. China yhj2001@sdu.edu.cn czchen@sdu.edu.cn +86 531 88395991 +86 531 88395991.
Huijun YuShenzhen Research Institute of Shandong University Shenzhen 518057 Guangdong P. R. China yhj2001@sdu.edu.cn czchen@sdu.edu.cn +86 531 88395991 +86 531 88395991.ORCID https://orcid.org/0000-0001-6015-3074
Chuanzhong ChenShenzhen Research Institute of Shandong University Shenzhen 518057 Guangdong P. R. China yhj2001@sdu.edu.cn czchen@sdu.edu.cn +86 531 88395991 +86 531 88395991.ORCID https://orcid.org/0000-0002-5653-5923

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Articular cartilage (AC) defects lack the ability to self-repair due to their avascular nature and the declined mitotic ability of mature chondrocytes. To date, cartilage tissue engineering using implanted scaffolds containing cells or growth factors is the most promising defect repair method. Scaffolds for cartilage tissue engineering have been comprehensively researched. As a promising scaffold biomaterial for AC defect repair, the properties of chitosan are summarized in this review. Strategies to composite chitosan with other materials, such as polymers (including collagen, gelatin, alginate, silk fibroin, poly-caprolactone, and poly-lactic acid) and bioceramics (including calcium phosphate, calcium polyphosphate, and hydroxyapatite) are presented. Methods to manufacture three-dimensional porous structures to support cell attachment and nutriment exchange have also been included.

Identifiers

PMID35542907
PMCPMC9077838

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.